Composition
- Active ingredients
- IMLUNESTRANT TOSYLATE EQ 200MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA218881.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Inluriyo
- Active substance
- imlunestrant tosylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Eli Lilly and Co
- Status
- Prescription
- FDA approval
- 25 Sept 2025
- Application
- NDA218881-001
- RxCUI
- 2725918